Two New Omicron Subvariants Gain Ground in the U.S.

THURSDAY, June 9, 2022 (HealthDay News) -- The omicron subvariants BA.4 and BA.5 are spreading rapidly in the United States, but it is not yet clear if they will trigger a new wave of infections or a surge in hospitalizations and deaths, experts say.
The subvariants now account for 13 percent of new coronavirus cases nationwide compared with 7.5 percent a week ago and 1 percent in early May, according to new estimates released Tuesday by the U.S. Centers for Disease Control and Prevention. That suggests that BA.4 and BA.5 could outcompete two other omicron subvariants, BA.2 and BA.2.12.1, which together account for the most cases at the moment, Denis Nash, Ph.D., of the CUNY Graduate School of Public Health & Health Policy in New York City, told The New York Times.
The subvariants have become common in parts of the Southern United States. In the region composed of Arkansas, Louisiana, New Mexico, Oklahoma, and Texas, BA.4 and BA.5 account for more than one in five infections, The Times reported.
Despite widespread immunity to the coronavirus, South Africa experienced a surge of cases in April and May that were fueled by BA.4 and BA.5. However, that wave was not as large as previous ones and deaths did not increase as steeply, Jeffrey Shaman, Ph.D., an infectious disease epidemiologist at Columbia University in New York City, told The Times.
But if the United States echoes South Africa's surge -- which is not certain -- the wave might be more modest than previous ones and cause smaller increases in hospitalizations and deaths, Nash suggested.
Related Posts
Study Finds Just One Dose of HPV Vaccine May Be Enough
TUESDAY, April 12, 2022 (HealthDay News) -- A single dose of human...
Breathing Dirty Air Could Raise Your Odds for Rheumatoid Arthritis
WEDNESDAY, March 16, 2022 (HealthDay News) -- Long-term exposure to air...
Los niños son más felices y sanos lejos de todas las pantallas, según un estudio
MIÉRCOLES, 29 de junio de 2022 (HealthDay News) -- Una nueva investigación...
Challenges Persist for Pediatric Clinical Trials
TUESDAY, March 22, 2022 (HealthDay News) -- Early discontinuation and...